Cellectis SA (NASDAQ:CLLS)
| 13.71 BATS BZX Real-Time Price As of 3:20pm ET |  +0.71 / +5.46%Today’s Change | 12.62 Today|||52-Week Range 34.71 | -49.33% Year-to-Date |
Latest CLLS News | Press Releases
No recent news for Cellectis SA.
Today’s Trading
| Previous close | 13.00 |
| Today’s open | 13.26 |
| Day’s range | 13.26 - 13.71 |
| Volume | 11,550 |
| Average volume (3 months) | 256,403 |
| Market cap | $591.8M |
Data as of 3:20pm ET, 07/28/2021
Growth & Valuation
| Earnings growth (last year) | +20.70% |
| Earnings growth (this year) | -22.34% |
| Earnings growth (next 5 years) | +1.50% |
| Revenue growth (last year) | +386.83% |
| P/E ratio | NM |
| Price/Sales | 15.55 |
| Price/Book | 2.13 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRNSMarinus Pharmaceutic... | +0.54 | +3.57% |
| ICPTIntercept Pharmaceut... | +0.37 | +2.26% |
| KDNYChinook Therapeutics... | +0.55 | +4.27% |
| ALBOAlbireo Pharma Inc | +1.00 | +3.52% |
Data as of 3:19pm ET, 07/28/2021
Financials
| Next reporting date | August 4, 2021 |
| EPS forecast (this quarter) | -$0.73 |
| Annual revenue (last year) | $73.9M |
| Annual profit (last year) | -$81.1M |
| Net profit margin | -109.64% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Paris, Ile-de-france |
Forecasts
